Page 176 - Orange Book Cumulative Supplement 10 October 2012
P. 176
A - 39
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE - QSYMIA
N022580 003 7056890 Jun 14, 2020 DP U-1262 NC Jul 17, 2015
7553818 Jun 14, 2020 U-1262
7659256 Jun 14, 2020 DP U-1262
7674776 Jun 14, 2020 DP U-1262
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE - QSYMIA
N022580 004 7056890 Jun 14, 2020 DP U-1262 NC Jul 17, 2015
7553818 Jun 14, 2020 U-1262
7659256 Jun 14, 2020 DP U-1262
7674776 Jun 14, 2020 DP U-1262
PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE
A076801 001 PC Feb 13, 2013
PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE
A076801 002 PC Feb 13, 2013
PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE
A076801 003 PC Feb 13, 2013
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN
N050684 001 8133883 Apr 14, 2023 DP U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN
N050684 002 8133883 Apr 14, 2023 DP U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN
N050684 003 8133883 Apr 14, 2023 DP U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN
N050684 004 8133883 Apr 14, 2023 DP U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER
N050750 001 8133883 Apr 14, 2023 DP U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER
N050750 002 8133883 Apr 14, 2023 DP U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER
N050750 003 8133883 Apr 14, 2023 DP U-282
POSACONAZOLE - NOXAFIL
N022003 001 8263600 Apr 01, 2022 DP
PREDNISOLONE ACETATE - FLO-PRED
N022067 001 7799331 Oct 11, 2028 DP U-139
7799331 Oct 11, 2028 DP U-1068
PREDNISOLONE ACETATE - FLO-PRED
N022067 002 7799331 Oct 11, 2028 DP U-139
7799331 Oct 11, 2028 DP U-1068
PREDNISONE - RAYOS
N202020 001 6488960 Mar 14, 2020 DP U-1267
6677326 Mar 14, 2020 DP U-1268
>A> 8309124 Apr 23, 2024 U-1292
